Unlocking Better Weight Loss: Combining GLP-1 Medications with Sermorelin Losing weight can be exciting, but it's important to do it in a way that protects your muscles and bones
A Certificate of Analysis relates only to the identified batch and reported tests
These drugs mimic or enhance the action of endogenous GLP-1 a hormone naturally secreted by intestinal L-cells in response to nutrient intake
DEM has been described as an excellent activator of the Nrf2 pathway in the HepG2 model (Bischoff et al
GLP-1: New Metrics, New Molecules, New Prices Topics We Cover: 00:00 New data from Harvard/Mass General may classify nearly 70% of adults as having obesity 03:00 A new oral triple agonist shows record-setting absorption rates 07:00 Fractal Healths Revita procedure: weight maintenance after stopping GLP-1s 12:00 Zepbound vial prices drop (full breakdown by dose) 16:00 Daves personal experience switching off Mounjaro and intense hunger return 22:00 Novo Nordisks EVOKE/EVOKE+ Alzheimers trial: what the data really means 29:00 Why GLP-1 neurological research is just getting started 33:00 Updates on access, partners, and major news coming soon for Medicare patients If youre on Wegovy, Mounjaro, Zepbound, Saxenda, Trulicity, or compounded versions, this episode gives you the insight and context you need to have more competent and confident conversations with your doctor

What To Do A 2025 SCOPE trial of overweight patients taking semaglutide for over a year looked at their long-term weight loss outcomes